Association of +3179G/A insulin-like growth factor-1 receptor polymorphism and insulin-like growth factor-1 serum level with systemic lupus erythematosus

Lupus

Volumn 22, Issue 13, 2013, Pages 1388-1393

  Stanilova, S A ^a   Ivanova, M G ^b   Karakolev, I A ^a   Stoilov, R M ^b   Rashkov, R K ^b   Manolova, I M ^c  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^c TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

IGF 1; IGF 1R; rs2229765; single nucleotide polymorphism; systemic lupus erythematosus

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; CONTROLLED STUDY; DISEASE ACTIVITY; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS;

IGF-1; IGF-1R; RS2229765; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOLOGICAL MARKERS; BULGARIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, IGF TYPE 1; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84887046036     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313502860     Document Type: Review

References (15)

1. Khan IU, Tsokos G, Kammer GM. Abnormal B cell transduction in systemic lupus erythematosus. Curr Dir Autoimmun. 2003 ; 6: 89-104
2. Bae YS, Bae SC, Lee SW, Yoo DH, Kim TY, Kim SY. Lupus flare associated with growth hormone. Lupus. 2001 ; 10: 448-450
3. Heemskerk V, Daemen M, Buurman W. Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev. 1999 ; 10: 5-14
4. Smith T. Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?. Pharmacol Rev. 2010 ; 62: 199-236
5. Matsumoto T, Tsurumoto T. Inappropriate serum levels of IGF-I andIGFBP-3 in patients with rheumatoid arthritis. Rheumatol (Oxford). 2002 ; 41: 352-353
6. Denko C, Malemud C. Age-related changes in Serum Growth Hormone, Insulin-like Growth Factor-1 and Somatostatin in System Lupus Erythematosus. BMC Musculoskeletal Disord. 2004 ; 5: 37-45
7. Bonafe M, Barbieri M, Marchegiani F, et al. Polymorphic variants of insulin-growth factor I receptor (IGF-IR) and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for evolutionary conserved mechanism of life span control. J Clin Endocrinol Metab. 2003 ; 88: 3299-3304
8. Albani D, Batelli S, Polito L, Vittori A, Pesaresi M, Gajo GB. A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" study. BMC Geriatr. 2009 ; 9: 19-26
9. Hahn WH, Suh JS, Cho BS. Polymorphisms of insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) contribute to pathologic progression in childhood IgA nephropathy. Growth Factors. 2011 ; 29: 8-13
10. Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S. Elevated Serum Insulin-like Growth Factor (IGF-1) and IGF Binding Protein-3 Levels in Patients with Systemic Sclerosis: Possible Role in Development of Fibrosis. J Rheumatol. 2008 ; 35: 2363-2371
11. Kimata H, Yoshida A. Differential effect of growth hormone and insulin-like growth factor-I, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells. Blood. 1994 ; 83: 1569-74
12. Baudler S, Baumgartl J, Hampel B, et al. Insulin-like growth factor-1 controls type 2 T cell-independent B cell response. J Immunol. 2005 ; 174: 5516-5525
13. Taguchi T, Takenouchi H, Matsui J, et al. Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell development. Exp Hematol. 2006 ; 34: 508-518
14. Kooijman R, Coppens A. Insulin-like growth factor-I stimulate IL-10 production in human T cells. J Leukocyte Biol. 2004 ; 76: 862-867
15. Douglas RS, Naik V, Hwang CJ, et al. B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. J Immunol. 2008 ; 181: 5768-5774